At a meeting in Vilnius, Lithuania, EHRN is launching its first project with the European Commission in the field of drug policy. The project, titled “Drug Policy Impact Assessment for Change in Central and Eastern Europe”, will focus on the Central and Eastern Europe region, with pilot actions in the three Baltic countries of Estonia, Latvia and Lithuania.

The aim of the project is to involve various groups – from legislators and law enforcement to civil society activists – to work on drug policy evaluation mechanisms and promote transparent and evidence-based decision-making processes for national drug policies. A strategic importance is given to obtaining a national and regional consensus on changes needed to meet the targets of EU Drugs Strategy and, in general, to improve public health and human rights in the area of drug policy.

A two-day meeting, taking place on 30-31 January, is dedicated to setting country-specific goals and objectives of the project, identifying partnerships in each country as well as starting the process of creating the methodology for drug policy impact assessment in the region.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.